Shilpa Medicare moves up on getting DCGI approval for ‘2-Deoxy2-Glucose’

01 Sep 2021 Evaluate

Shilpa Medicare is currently trading at Rs. 598.95, up by 22.40 points or 3.89% from its previous closing of Rs. 576.55 on the BSE.

The scrip opened at Rs. 566.05 and has touched a high and low of Rs. 611.20 and Rs. 558.20 respectively. So far 52609 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 670.95 on 22-Jul-2021 and a 52 week low of Rs. 317.05 on 19-Mar-2021.

Last one week high and low of the scrip stood at Rs. 611.20 and Rs. 558.20 respectively. The current market cap of the company is Rs. 4938.90 crore.

The promoters holding in the company stood at 53.25%, while Institutions and Non-Institutions held 18.08% and 28.68% respectively.

Shilpa Medicare has received Drugs Controller General of India (DCGI) approval for ‘2-Deoxy2-Glucose’ (Bulk & Oral Powder). The bulk is manufactured by Shilpa Medicare, API facility in Raichur,' Karnataka. The Oral Powder is manufactured by its subsidiary, Shilpa Therapeutics, facility in Hyderabad, Telangana. 2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients. The product will be available with a brand name '2-DGSHIL'.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

530.70 -4.45 (-0.83%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.